Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan registered : validation in chronic hepatitis C

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan registered : validation in chronic hepatitis C

A novel controlled attenuation parameter (CAP) has been developed for Fibroscan registered to assess liver steatosis, simultaneously with liver stiffness measurement (LSM). We assessed CAP diagnostic accuracy in a large cohort of patients with chronic hepatitis C (CHC) virus. A total of 615 patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of viral hepatitis 2012-04, Vol.19 (4), p.244-253
Hauptverfasser: Sasso, M, Tengher-Barna, I, Ziol, M, Miette, V, Fournier, C, Sandrin, L, Poupon, R, Cardoso, A-C, Marcellin, P, Douvin, C, de Ledinghen, V, Trinchet, J-C, Beaugrand, M
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A novel controlled attenuation parameter (CAP) has been developed for Fibroscan registered to assess liver steatosis, simultaneously with liver stiffness measurement (LSM). We assessed CAP diagnostic accuracy in a large cohort of patients with chronic hepatitis C (CHC) virus. A total of 615 patients with CHC, who underwent both Fibroscan registered and liver biopsy, were analysed. Fibrosis was graded using METAVIR score. Steatosis was categorized by visual assessment as S0: steatosis in
ISSN:1352-0504
1365-2893
DOI:10.1111/j.1365-2893.2011.01534.x